|
| 35129530 | Low Titer Group O Whole Blood In Injured Children Requiring Massive Transfusion. | Ann Surg | 2023 |
| 37952133 | Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia. | N Engl J Med | 2023 |
| 37743191 | Optimizing RBC Transfusion Outcomes in Patients with Acute Illness and in the Chronic Transfusion Setting. | Transfus Med Rev | 2023 |
| 37889553 | TEG-based transfusion protocol is associated with decreased blood product use without increased risk of hemoperitoneum. | Hepatol Commun | 2023 |
| 37639579 | Incompatible plasma transfusion is not associated with increased mortality in civilian trauma patients. | Hematology | 2023 |
| 37599188 | Prophylactic Platelet Transfusion: Is There Evidence of Benefit, Harm, or No Effect? | Transfus Med Rev | 2023 |
| 37081734 | Considering equality in transfusion medicine practice. | Br J Haematol | 2023 |
| 37005871 | Proceedings of the 2022 NHLBI and OASH state of the science in transfusion medicine symposium. | Transfusion | 2023 |
| 36971012 | Receipt of low titer group O whole blood does not lead to hemolysis in children weighing less than 20 kilograms. | Transfusion | 2023 |
| 37067374 | Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients. | Transfusion | 2023 |
| 37358345 | How do we⿦consistently provide high-dose granulocyte products for transfusions in neutropenic patients? | Transfusion | 2023 |
| 37027803 | Hemostatic In Vitro Properties of Novel Plasma Supernatants Produced from Late-storage Low-titer Type O Whole Blood. | Anesthesiology | 2023 |
| 36607150 | Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma. | Hematology | 2023 |
| 36494878 | Optimizing interpretation of survival studies of fresh and aged transfused biotin-labeled RBCs. | Transfusion | 2023 |
| 36044391 | Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia. | Blood Adv | 2023 |
| 36134727 | Wider perspectives: It's a changing world-The use of ABO-incompatible plasma for resuscitating massively bleeding patients. | Br J Haematol | 2023 |
| 35321643 | Sex-specific genetic modifiers identified susceptibility of cold stored red blood cells to osmotic hemolysis. | BMC Genomics | 2022 |
| 35348444 | CD4<sup>+</sup> T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-Dependent. | Am J Respir Crit Care Med | 2022 |
| 35796302 | Toward a more complete understanding of who will benefit from prehospital transfusion. | Transfusion | 2022 |
| 35667085 | Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial. | Blood | 2022 |
| 35748690 | Receipt of at least 4 units of low titer group O whole blood with titer <100 does not lead to hemolysis in adult trauma patients. | Transfusion | 2022 |
| 35253913 | Administration of blood products in the prehospital setting can decrease trauma patient mortality. | Transfusion | 2022 |
| 35081595 | Prehospital low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial. | J Trauma Acute Care Surg | 2022 |
| 33215723 | Platelet transfusion is associated with 90-day and 1-year mortality for adult patients requiring veno-arterial extracorporeal membrane oxygenation. | Vox Sang | 2021 |
| 33491789 | The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusion. | Vox Sang | 2021 |
| 33811640 | Injured recipients of low-titer group O whole blood have similar clinical outcomes compared to recipients of conventional component therapy: A single-center, retrospective study. | Transfusion | 2021 |
| 33775237 | Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review. | Hematology | 2021 |
| 34932836 | Transfusion thresholds for guiding red blood cell transfusion. | Cochrane Database Syst Rev | 2021 |
| 34411495 | The rebirth of the cool: a narrative review of the clinical outcomes of cold stored low titer group O whole blood recipients compared to conventional component recipients in trauma. | Hematology | 2021 |
| 34407339 | Early Convalescent Plasma for High-Risk Outpatients with Covid-19. | N Engl J Med | 2021 |
| 34606578 | Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. | JAMA | 2021 |
| 34013981 | International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses. | Vox Sang | 2021 |
| 34013968 | International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary. | Vox Sang | 2021 |
| 34269441 | Safety profile of low-titer group O whole blood in pediatric patients with massive hemorrhage. | Transfusion | 2021 |
| 34269438 | Rate of RhD-alloimmunization after the transfusion ofâ¿¿multiple RhD-positive primary red blood cell-containing products. | Transfusion | 2021 |
| 34058023 | Plasma trial: Pilot randomized clinical trial to determine safety and efficacy of plasma transfusions. | Transfusion | 2021 |
| 34228353 | An unusual case of anti-D detection in two consecutive D+ patient samples: Antibody carryover on an automated gel platform. | Transfusion | 2021 |
| 34047385 | Adverse events after low titer group O whole blood versus component product transfusion in pediatric trauma patients: A propensity-matched cohort study. | Transfusion | 2021 |
| 33368319 | Randomized controlled trial of 7, 28, vs 42â¿¿day stored red blood cell transfusion on oxygen delivery (VO<sub>2</sub> max) and exercise duration. | Transfusion | 2021 |
| 30635658 | Mother-child histocompatibility and risk of rheumatoid arthritis and systemic lupus erythematosus among mothers. | Genes Immun | 2020 |
| 32061102 | The evanescence and persistence of RBC alloantibodies in blood donors. | Transfusion | 2020 |
| 32027394 | How do you⿦ decide which platelet bacterial risk mitigation strategy to select for your hospital-based transfusion service? | Transfusion | 2020 |
| 31794885 | Equivalent inpatient mortality among direct-acting oral anticoagulant and warfarin users presenting with major hemorrhage. | Thromb Res | 2020 |
| 31850522 | The epidemiology of platelet transfusions: an analysis of platelet use at 12â¿¿US hospitals. | Transfusion | 2020 |
| 33275693 | The use of premedications for platelet transfusions in pediatric patients. | Hematology Am Soc Hematol Educ Program | 2020 |
| 33275687 | How well do platelets prevent bleeding? | Hematology Am Soc Hematol Educ Program | 2020 |
| 33007039 | Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a "humanized" G6PD A- mouse model. | PLoS One | 2020 |
| 32932312 | Whole Blood is Superior to Component Transfusion for Injured Children: A Propensity Matched Analysis. | Ann Surg | 2020 |
| 32905629 | NT-proBNP levels in the identification and classification of pulmonary transfusion reactions. | Transfusion | 2020 |
| 32478860 | Hemolytic markers following the transfusion of uncrossmatched, cold-stored, low-titer, group O+ whole blood in civilian trauma patients. | Transfusion | 2020 |